Treating psoriatic arthritis to target: discordance between physicians and patients' assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort.

MLA

Ferreira, Manoela Fantinel, et al. “Treating Psoriatic Arthritis to Target: Discordance between Physicians and Patients’ Assessment, Non-Adherence, and Restricted Access to Drugs Precluded Therapy Escalation in a Real-World Cohort.” Clinical Rheumatology, vol. 38, no. 3, Mar. 2019, pp. 961–68. EBSCOhost, https://doi.org/10.1007/s10067-018-4383-9.

APA

Ferreira, M. F., Kohem, C. L., Xavier, R. M., Abegg, E., Martins, O. S., Resmini, M. B., de Mello, A. L., de Almeida Menegat, F., Hax, V., Gasparin, A. A., Brenol, C. V., de Andrade, N. P. B., Viecceli, D., Brenol, J. C. T., & Palominos, P. E. (2019). Treating psoriatic arthritis to target: discordance between physicians and patients’ assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort. Clinical Rheumatology, 38(3), 961–968. https://doi.org/10.1007/s10067-018-4383-9

Chicago

Ferreira, Manoela Fantinel, Charles Lubianca Kohem, Ricardo Machado Xavier, Everton Abegg, Otavio Silveira Martins, Marcus Barg Resmini, Ariele Lima de Mello, et al. 2019. “Treating Psoriatic Arthritis to Target: Discordance between Physicians and Patients’ Assessment, Non-Adherence, and Restricted Access to Drugs Precluded Therapy Escalation in a Real-World Cohort.” Clinical Rheumatology 38 (3): 961–68. doi:10.1007/s10067-018-4383-9.